Molecular Partners AG revenue for the last year amounted to 8.31 M USD, the most of which — 8.36 M USD — came from its highest performing source at the moment, Biopharmaceutical Products, the year earlier bringing 205.03 M USD. The greatest contribution to the revenue figure was made by Switzerland — last year it brought Molecular Partners AG 8.36 M USD, and the year before that — 194.59 M USD.